Assessing prescribing practices of clozapine before and after the implementation of an updated risk evaluation and mitigation strategy

INTRODUCTION: Clozapine is an atypical antipsychotic medication approved for treatment-resistant schizophrenia and suicidal behavior in schizophrenia or schizoaffective disorders. Despite its therapeutic efficacy, clozapine is associated with several adverse effects, including agranulocytosis. In la...

Descripción completa

Detalles Bibliográficos
Autores principales: Curry, Brent, Palmer, Emma, Mounce, Crystal, Smith, Gilbert, Shah, Vital
Formato: Online Artículo Texto
Lenguaje:English
Publicado: College of Psychiatric & Neurologic Pharmacists 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007735/
https://www.ncbi.nlm.nih.gov/pubmed/29955547
http://dx.doi.org/10.9740/mhc.2018.03.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6007735/
https://www.ncbi.nlm.nih.gov/pubmed/29955547
http://dx.doi.org/10.9740/mhc.2018.03.063

Ejemplares similares